Kaposi's sarcoma-associated herpesvirus (KSHV) is associated with three malignancies—
Kaposi's sarcoma (KS), primary effusion lymphoma (PEL), and multicentric Castleman's …

Kaposi's sarcoma-associated herpesvirus (KSHV) is the causative agent of several human
cancers such as Kaposi's sarcoma (KS), which represents the most common AIDS …

Kaposi's sarcoma (KS)-associated herpesvirus (KSHV) is associated with KS, primary
effusion lymphoma (PEL), and multicentric Castleman disease (MCD). To ensure its own …

Kaposi's sarcoma-associated herpesvirus (KSHV) has an etiologic role in Kaposi's sarcoma,
primary effusion lymphoma, and multicentric Castleman's disease. These diseases are most …

Kaposi's sarcoma-associated herpesvirus is an oncogenic γ-herpesvirus that causes latent
infection in humans. In cells, the viral genome adopts a highly organized chromatin …

Kaposi sarcoma-associated herpesvirus (KSHV), also called human herpesvirus 8 (HHV-8),
is associated with a specific subset of lymphoproliferative disorders. These include two main …

Productive herpesvirus infection requires a profound, time-controlled remodeling of the viral
transcriptome and proteome. To gain insights into the genomic architecture and gene …

Kaposi's sarcoma-associated herpesvirus (KSHV) is a human gammaherpesvirus with latent
and lytic reactivation cycles. The mechanism by which KSHV evades the innate immune …

The search for a transmissible infectious agent as the cause of Kaposi's sarcoma lead to the
discovery in 1994 of Kaposi's sarcoma-associated herpesvirus (KSHV), also known as …

Kaposi's sarcoma-associated herpesvirus (KSHV) is the causative agent of three human
proliferative disorders, namely, Kaposi's sarcoma, primary effusion lymphomas (PEL), and …